SCHEMBL396619

SCHEMBL396619

O=S(=O)(Cl)c1ccc(CCl)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 1/20 0.50
▸ HSD17B10 Q99714 1/20 0.50
▸ TDP1 Q9NUW8 1/20 0.50
▸ CA2 P00918 13/20 0.46
▸ CA1 P00915 11/20 0.46
▸ CA12 O43570 8/20 0.38
▸ CA9 Q16790 8/20 0.38
▸ CA14 Q9ULX7 5/20 0.38
▸ CA4 P22748 4/20 0.38
▸ CA6 P23280 4/20 0.38
▸ CA5A P35218 4/20 0.38
▸ CA7 P43166 4/20 0.38
▸ CA5B Q9Y2D0 4/20 0.38
▸ MAPT P10636 1/20 0.37
▸ PSIP1 O75475 1/20 0.35
▸ F2 P00734 1/20 0.34
▸ TP53 P04637 1/20 0.34
▸ CYP1A2 P05177 1/20 0.34
▸ CYP2D6 P10635 1/20 0.34
▸ TSHR P16473 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11294967 0.93 ALDH1A1 (0.44) ALDH1A1HSD17B10TDP1CA2CA1
SCHEMBL11582128 0.82 ALDH1A1 (0.52) ALDH1A1HSD17B10TDP1CA2CA1
SCHEMBL2263958 0.82 ALDH1A1 (0.52) ALDH1A1HSD17B10TDP1CA2CA1
SCHEMBL14834008 0.82 ALDH1A1 (0.52) ALDH1A1HSD17B10TDP1CA2CA1
SCHEMBL3539406 0.82 CYP3A4 (0.52) ALDH1A1HSD17B10CA2CA1CA12
SCHEMBL27609957 0.81 ALDH1A1 (0.46) ALDH1A1HSD17B10TDP1CA2CA1
SCHEMBL651902 0.81 ALDH1A1 (0.71) ALDH1A1HSD17B10TDP1CA2CA1
SCHEMBL4125638 0.80 CA2 (0.46) ALDH1A1CA2CA1CA12CA9
SCHEMBL22363546 0.79 CA2 (0.44) CA2CA1CA12CA9CA14
SCHEMBL1122583 0.78 ALDH1A1 (0.48) ALDH1A1HSD17B10TDP1CA2CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 47 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-104678028-A Pretreatment and detection method for biogen amine neurotransmitter and detection kit INST PHARM & TOXICOLOGY AMMS 2015-06-03 — — CN claimed
US-20260092074-A1 Annelated Pyridines as Steroidogenesis Inhibitors, Preparation Method and Use Thereof GUANGZHOU VINNOCENT PHARMACEUTICAL LTD (CN) 2026-04-02 — — US disclosed
US-20260028447-A1 POLYMER, THIOPHENE COMPOUND, CONDUCTIVE MEMBER, AND ELECTRONIC PART TDK CORPORATION (JP) 2026-01-29 — — US disclosed
EP-4651902-A2 ASGPR BINDING COMPOUNDS AND CONJUGATES Lycia Therapeutics, Inc. (US) 2025-11-26 — — EP disclosed
EP-4574830-A1 ANNELATED PYRIDINE STEROID SYNTHETASE INHIBITOR, PREPARATION METHOD THEREFOR, AND USE THEREOF Guangzhou Vinnocent Pharmaceutical Limited (CN) 2025-06-25 — — EP disclosed
WO-2025049640-A1 MACROLIDE-NOX4 CONJUGATES AND USES THEREOF THE UNITED STATES GOVERNMENT AS REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS (US) 2025-03-06 — — WO disclosed
CN-119522246-A Polymer, thiophene compound, conductive member, and electronic component TDK株式会社 2025-02-25 — — CN disclosed
WO-2024155747-A2 ASGPR BINDING COMPOUNDS AND CONJUGATES LYCIA THERAPEUTICS, INC. (US) 2024-07-25 — — WO disclosed
CN-111689929-B Sulfur fluoride (VI) compound and preparation method thereof 斯克里普斯研究所 2024-05-31 — — CN disclosed
WO-2024024876-A1 POLYMER, THIOPHENE COMPOUND, CONDUCTIVE MEMBER, AND ELECTRONIC PART TDK株式会社 2024-02-01 — — WO disclosed
EP-0178775-B1 FLUORESCENT INDICATOR DYES FOR CALCIUM IONS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 1988-11-09 — — EP disclosed
US-4603209-A STILBENE-TYPE FLUOROPHORE, TWO AMINODIACETIC ACID MOIETIES THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 1986-07-29 — — US disclosed
EP-0009787-B2 PROCESS FOR THE MONOHALOGENATION OF ALKYLBENZENES IN ALPHA POSITION BAYER AG (DE) 1986-07-09 — — EP disclosed
EP-0178775-A2 Fluorescent indicator dyes for calcium ions THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 1986-04-23 — — EP disclosed
US-4331821-A ULTRAVIOLET RADIATION OF A VAPORIZED ALKYLBENZEN AND HALOGEN GAS MIXTURE BAYER AKTIENGESELLSCHAFT (DE) 1982-05-25 — — US disclosed
EP-0009787-B1 PROCESS FOR THE MONOHALOGENATION OF ALKYLBENZENES IN ALPHA POSITION BAYER AG (DE) 1982-01-13 — — EP disclosed
US-4265633-A Process for the manufacture of vat dyes CIBA-GEIGY AG (CH) 1981-05-05 — — US disclosed
EP-0009787-A2 Process for the monohalogenation of alkylbenzenes in alpha position BAYER AG (DE) 1980-04-16 — — EP disclosed
US-4141808-A Manganese carbonyl-sulfonyl chloride photoinitiators for radiation polymerizable unsaturated compounds EASTMAN KODAK COMPANY (US) 1979-02-27 — — US disclosed
US-4122079-A Reactive azo dyestuffs from diazotized sulfo-amino naphthalenes and diaminosulfobenzenes BAYER AKTIENGESELLSCHAFT (DE) 1978-10-24 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260028447-A1 POLYMER, THIOPHENE COMPOUND, CONDUCTIVE MEMBER, AND ELECTRONIC PART AFF1, KCNA1, AFF2 ALDH1A1 656/4885HSD17B10 3636/4885TDP1 2442/4885
US-20260092074-A1 Annelated Pyridines as Steroidogenesis Inhibitors, Preparation Method and Use Thereof STS, NR5A1, CYP21A2 ALDH1A1 610/4885HSD17B10 80/4885TDP1 3740/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback